Blood test and treatment for vivax malaria in Ethiopia and Madagascar
Part of Infections clinical trials.
This trial tests whether using a blood test to find and treat people infected with a type of malaria called Plasmodium vivax can reduce the spread of the disease. It may help you and your community stay healthier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You plan to stay in the study area for at least the next month.
- You are older than 12 months (so babies under 1 year old cannot join).
- You agree to take part and are willing to follow the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how well a malaria treatment plan works for people with P. vivax malaria who don’t have another malaria type at the same time. It aims to see whether adding or using different medicines (ACT vs chloroquine with tafenoquine) helps clear infection and prevent return of disease.
This study compares two medicines (tafenoquine and primaquine) taken with chloroquine to treat P. vivax malaria. It aims to see which is safer and works better in Indian participants aged 2 to 64.
This trial tests a two-drug combination to safely and quickly clear all stages of P. vivax malaria from your body. You must have confirmed vivax malaria, be within a certain weight range, and agree to hospital stay and follow-up visits over 6 months.
This trial tests the safety and immune response of an experimental vaccine called Vivaxin, designed to protect against malaria caused by the Plasmodium vivax parasite. Healthy adults aged 18–59 who have never had malaria may be able to join.
This study gives healthy volunteers a controlled infection with a type of malaria (vivax) to see how the infection behaves and how well curative anti-malaria medicine works. It may help researchers better design and test future malaria vaccines and treatments.
This Phase 3 trial tests whether giving malaria medicine to people in high-risk households (a “mass drug administration” campaign) can stop local relapses and eliminate vivax malaria. If you live close to a recent malaria case, you may be offered a preventive dose, based on age and medical safety checks.
Hear when a new Malaria Vivax trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.